Treatment of cells with the small molecule Bcl2 inhibitor BDA-366 or Bcl2 depletion using siRNA was able to induce synthetic lethal phenotype in PTEN-/- CRC cells (Figure 4H-J). Here, BCL2 is linked to colorectal carcinoma.